Rigel Pharmaceuticals | DEBITO



Debt Cambiamento Data
Amgen USD 57.38B 2.72B 2025-03
Arrowhead Research USD 388.24M 21.18M 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Celldex Therapeutics USD 0 0 2025-03
Daiichi Sankyo JPY 101.33B 97M 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Halozyme Therapeutics USD 1.51B 1.65M 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Ligand Pharmaceuticals USD 24K 0 2025-03
MacroGenics USD 0 0 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Ultragenyx Pharmaceutical USD 0 0 2024-12
Veracyte USD 50.5M 50.5M 2025-03



Rigel Pharmaceuticals DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.